This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novartis Ag. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Max Woisetschlager: Innovator in Immunology
Introduction
Max Woisetschlager is a notable inventor based in Perchtoldsdorf, Austria. He has made significant contributions to the field of immunology, particularly through his innovative research and development of new compounds.
Latest Patents
Woisetschlager holds a patent for "Phenylpyrimidine amines as IgE inhibitors." This patent describes an amine that is substituted by phenyl-substituted pyrimidine, along with a third substituent, and its application as an immunoglobulin E (IgE) inhibitor. This invention has the potential to impact treatments related to allergic responses.
Career Highlights
Throughout his career, Max Woisetschlager has been associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on groundbreaking research that addresses critical health issues.
Collaborations
Woisetschlager has collaborated with esteemed colleagues, including Murty Bulusu and Peter Ettmayer. These partnerships have fostered an environment of innovation and have contributed to the advancement of their shared goals in the field of immunology.
Conclusion
Max Woisetschlager's contributions to immunology through his patent and work at Novartis AG highlight his role as a significant inventor in the field. His innovative approach continues to pave the way for advancements in medical science.